CERo Therapeutics Holdings, Inc.
CERO
$0.8899
-$0.0579-6.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.25M | 3.38M | 3.65M | 4.59M | 1.52M |
| Total Receivables | -- | -- | 87.40K | 162.10K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 274.70K | 334.30K | 511.50K | 746.00K | 368.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 187.00K | -- | -- | -- | 79.80K |
| Total Current Assets | 3.71M | 3.71M | 4.25M | 5.50M | 1.97M |
|
|
|||||
| Total Current Assets | 3.71M | 3.71M | 4.25M | 5.50M | 1.97M |
| Net Property, Plant & Equipment | 1.99M | 2.28M | 2.57M | 2.87M | 3.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 500.00K | 500.00K | 550.00K | 683.30K | -- |
| Total Assets | 6.21M | 6.49M | 7.37M | 9.05M | 5.13M |
|
|
|||||
| Total Accounts Payable | 4.51M | 6.67M | 6.35M | 7.06M | 1.67M |
| Total Accrued Expenses | 1.91M | 1.69M | 1.16M | 294.30K | 144.60K |
| Short-term Debt | -- | 102.30K | 253.20K | 402.50K | 599.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 876.40K | 931.00K | 821.30K | 794.90K | 769.10K |
| Total Finance Division Other Current Liabilities | 105.50K | 30.00K | 200.00K | 3.10M | 322.00K |
| Total Other Current Liabilities | 105.50K | 30.00K | 200.00K | 3.10M | 322.00K |
| Total Current Liabilities | 7.40M | 9.42M | 8.78M | 11.65M | 3.51M |
|
|
|||||
| Total Current Liabilities | 7.40M | 9.42M | 8.78M | 11.65M | 3.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 102.30K | 253.20K | 402.50K | 599.70K |
| Capital Leases | 699.10K | 771.50K | 1.07M | 1.37M | 1.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 13.70K | -- |
| Total Liabilities | 8.10M | 10.19M | 9.85M | 13.03M | 5.08M |
|
|
|||||
| Common Stock & APIC | 67.14M | 66.38M | 57.64M | 54.00M | 1.03M |
| Retained Earnings | -70.92M | -71.59M | -67.36M | -64.91M | -43.09M |
| Treasury Stock & Other | -1.30M | -2.07M | -2.20M | -2.50M | -- |
| Total Common Equity | -5.07M | -7.29M | -11.92M | -13.42M | -42.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.18M | 3.58M | 9.44M | 9.44M | 42.10M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.18M | 3.58M | 9.44M | 9.44M | 42.10M |
|
|
|||||
| Total Common Equity | -5.07M | -7.29M | -11.92M | -13.42M | -42.06M |
| Total Preferred Equity | 3.18M | 3.58M | 9.44M | 9.44M | 42.10M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.89M | -3.70M | -2.48M | -3.98M | 43.60K |
|
|
|||||